Delta 9 Cannabis Stock Fundamentals
| DLTNF Stock | USD 0.01 0.00 0.00% |
Delta 9 Cannabis fundamentals help investors to digest information that contributes to Delta 9's financial success or failures. It also enables traders to predict the movement of Delta Pink Sheet. The fundamental analysis module provides a way to measure Delta 9's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Delta 9 pink sheet.
Delta |
Delta 9 Cannabis Company Operating Margin Analysis
Delta 9's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Delta 9 Operating Margin | (0.25) % |
Most of Delta 9's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Delta 9 Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Delta 9 Cannabis has an Operating Margin of -0.2531%. This is 99.28% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 95.41% lower than that of the firm.
Delta 9 Cannabis Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Delta 9's current stock value. Our valuation model uses many indicators to compare Delta 9 value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Delta 9 competition to find correlations between indicators driving Delta 9's intrinsic value. More Info.Delta 9 Cannabis is rated # 4 in return on equity category among its peers. It is rated # 5 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Delta 9's earnings, one of the primary drivers of an investment's value.Delta Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Delta 9's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Delta 9 could also be used in its relative valuation, which is a method of valuing Delta 9 by comparing valuation metrics of similar companies.Delta 9 is currently under evaluation in operating margin category among its peers.
Delta Fundamentals
| Return On Equity | -0.91 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (0.33) % | |||
| Operating Margin | (0.25) % | |||
| Current Valuation | 54.59 M | |||
| Shares Outstanding | 149.01 M | |||
| Shares Owned By Insiders | 37.09 % | |||
| Price To Book | 0.68 X | |||
| Price To Sales | 0.13 X | |||
| Revenue | 62.29 M | |||
| Gross Profit | 17.32 M | |||
| EBITDA | (1.17 M) | |||
| Net Income | (11.18 M) | |||
| Cash And Equivalents | 13.49 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 2.48 M | |||
| Debt To Equity | 3.50 % | |||
| Current Ratio | 1.41 X | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (775.48 K) | |||
| Earnings Per Share | (0.09) X | |||
| Number Of Employees | 210 | |||
| Beta | 1.09 | |||
| Market Capitalization | 8.48 M | |||
| Total Asset | 74.78 M | |||
| Z Score | 1.8 | |||
| Net Asset | 74.78 M |
About Delta 9 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Delta 9 Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Delta 9 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Delta 9 Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Delta 9 Cannabis Inc. operates as an integrated cannabis company. Delta 9 Cannabis Inc. was incorporated in 2001 and is headquartered in Winnipeg, Canada. Delta 9 operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 210 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Delta Pink Sheet
Delta 9 financial ratios help investors to determine whether Delta Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Delta with respect to the benefits of owning Delta 9 security.